Table 3.
Associations of urinary ORM1/Cr level with bladder cancer
Clinical feature | Number | Urinary GC levels (ng/mg) | P |
---|---|---|---|
Age ≥65 years | 52 | 6988.25±3107.29 | 0.256 |
Age <65 years | 60 | 7401.97±4451.57 | |
Male | 97 | 7257.12±4297.54 | 0.548 |
Female | 15 | 6806.27±3317.95 | |
With diabetes | 34 | 6884.79±4187.56 | 0.741 |
Without diabetes | 78 | 7647.29±3533.47 | |
With hypertension | 45 | 7579.46±3557.75 | 0.642 |
Without hypertension | 67 | 6952.42±3972.41 | |
With hematuria | 61 | 7502.19±3788.85 | 0.756 |
Without hematuria | 51 | 7009.85±4387.69 | |
With urinary inflammation | 40 | 6652.58±4477.84 | <0.0001* |
Without urinary inflammation | 72 | 7290.58±4156.75 | |
New cases | 66 | 7467.87±3719.97 | 0.256 |
Recurrences | 46 | 6647.45±3859.74 | |
No metastasis | 91 | 7002.36±2998.69 | 0.113 |
Metastasis | 21 | 8045.45±4841.74 | |
Low grade non-invasive papillary urothelial carcinoma | 39 | 5313.35±1341.39 | <0.0001* |
High grade non-invasive papillary urothelial carcinoma | 36 | 5892.76±1943.94 | |
Infiltrating urothelial carcinoma | 37 | 10376.49±2677.76 |
Data are expressed as mean ± SD. *Significant *P<0.05.